Concepts (137)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Antitubercular Agents | 6 | 2021 | 1374 | 1.940 |
Why?
|
Heart Failure | 9 | 2024 | 11833 | 1.350 |
Why?
|
Tuberculosis, Multidrug-Resistant | 4 | 2021 | 931 | 1.240 |
Why?
|
Heart-Assist Devices | 3 | 2023 | 1291 | 1.210 |
Why?
|
Cardiomyopathy, Dilated | 2 | 2024 | 819 | 1.140 |
Why?
|
Prealbumin | 2 | 2024 | 222 | 1.040 |
Why?
|
Tuberculosis, Pulmonary | 3 | 2022 | 832 | 1.040 |
Why?
|
Nitric Oxide | 3 | 2024 | 2142 | 1.010 |
Why?
|
Mycobacterium tuberculosis | 3 | 2022 | 1905 | 0.980 |
Why?
|
Tuberculosis, Pleural | 1 | 2022 | 13 | 0.860 |
Why?
|
Tuberculosis, Osteoarticular | 1 | 2022 | 26 | 0.850 |
Why?
|
Amyloid Neuropathies, Familial | 1 | 2024 | 150 | 0.770 |
Why?
|
Natriuretic Peptide, Brain | 3 | 2024 | 1705 | 0.730 |
Why?
|
Hypertension | 4 | 2024 | 8594 | 0.720 |
Why?
|
Carpal Tunnel Syndrome | 1 | 2024 | 303 | 0.720 |
Why?
|
Isoniazid | 2 | 2020 | 283 | 0.700 |
Why?
|
Rotavirus | 1 | 2021 | 111 | 0.700 |
Why?
|
Extensively Drug-Resistant Tuberculosis | 1 | 2020 | 85 | 0.680 |
Why?
|
Nitroimidazoles | 1 | 2020 | 117 | 0.660 |
Why?
|
Heart Transplantation | 2 | 2023 | 3214 | 0.650 |
Why?
|
Oxazoles | 1 | 2020 | 198 | 0.640 |
Why?
|
Hyperlipidemias | 1 | 2024 | 782 | 0.630 |
Why?
|
Biological Specimen Banks | 1 | 2024 | 777 | 0.630 |
Why?
|
Neuritis | 1 | 2018 | 36 | 0.630 |
Why?
|
Portoenterostomy, Hepatic | 1 | 2018 | 22 | 0.620 |
Why?
|
Respiratory Insufficiency | 2 | 2024 | 1225 | 0.620 |
Why?
|
Aminoglycosides | 1 | 2018 | 163 | 0.610 |
Why?
|
Gastroplasty | 1 | 2020 | 157 | 0.610 |
Why?
|
Foreign-Body Migration | 1 | 2020 | 218 | 0.600 |
Why?
|
Biliary Atresia | 1 | 2018 | 88 | 0.580 |
Why?
|
Cholangitis | 1 | 2018 | 113 | 0.560 |
Why?
|
Gastric Mucosa | 1 | 2020 | 599 | 0.560 |
Why?
|
Hypercholesterolemia | 1 | 2024 | 1155 | 0.550 |
Why?
|
Dyslipidemias | 1 | 2024 | 895 | 0.530 |
Why?
|
Atrial Fibrillation | 2 | 2024 | 5198 | 0.500 |
Why?
|
Antihypertensive Agents | 1 | 2024 | 2063 | 0.470 |
Why?
|
Neurotoxicity Syndromes | 1 | 2018 | 299 | 0.460 |
Why?
|
Prostheses and Implants | 1 | 2020 | 1274 | 0.420 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2018 | 537 | 0.420 |
Why?
|
Tuberculosis | 3 | 2022 | 2002 | 0.420 |
Why?
|
Administration, Inhalation | 3 | 2024 | 1155 | 0.410 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2020 | 1132 | 0.410 |
Why?
|
Brain Diseases | 1 | 2021 | 1540 | 0.400 |
Why?
|
Nutritional Status | 1 | 2019 | 1604 | 0.370 |
Why?
|
Genetic Predisposition to Disease | 4 | 2024 | 17750 | 0.350 |
Why?
|
Vitamin D Deficiency | 1 | 2019 | 1379 | 0.340 |
Why?
|
Blood Pressure | 5 | 2024 | 8523 | 0.320 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2023 | 2286 | 0.320 |
Why?
|
Rifampin | 2 | 2022 | 341 | 0.320 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2024 | 3329 | 0.310 |
Why?
|
Atherosclerosis | 1 | 2023 | 3525 | 0.280 |
Why?
|
Humans | 38 | 2024 | 759255 | 0.270 |
Why?
|
Vitamin D | 2 | 2022 | 3291 | 0.270 |
Why?
|
Nutrition Surveys | 2 | 2024 | 1721 | 0.270 |
Why?
|
Creatinine | 2 | 2023 | 1907 | 0.250 |
Why?
|
Risk Factors | 8 | 2024 | 74167 | 0.240 |
Why?
|
Male | 20 | 2024 | 358719 | 0.240 |
Why?
|
Coronary Artery Disease | 1 | 2024 | 6649 | 0.230 |
Why?
|
Female | 20 | 2024 | 390240 | 0.230 |
Why?
|
Sex Characteristics | 2 | 2024 | 2627 | 0.220 |
Why?
|
Child | 14 | 2022 | 79623 | 0.210 |
Why?
|
Natriuretic Peptides | 1 | 2023 | 156 | 0.200 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2023 | 322 | 0.200 |
Why?
|
Peptide Fragments | 2 | 2024 | 5120 | 0.190 |
Why?
|
Glycogen Storage Disease | 1 | 2020 | 41 | 0.180 |
Why?
|
Subacute Sclerosing Panencephalitis | 1 | 2020 | 26 | 0.180 |
Why?
|
Osteogenesis Imperfecta | 1 | 2021 | 81 | 0.180 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2023 | 461 | 0.170 |
Why?
|
Vasodilator Agents | 1 | 2023 | 976 | 0.160 |
Why?
|
RNA Splicing | 1 | 2024 | 915 | 0.160 |
Why?
|
Minors | 1 | 2019 | 58 | 0.160 |
Why?
|
United States | 5 | 2024 | 72237 | 0.160 |
Why?
|
Anal Canal | 1 | 2021 | 373 | 0.160 |
Why?
|
Risk Assessment | 3 | 2024 | 24049 | 0.160 |
Why?
|
Middle Aged | 8 | 2024 | 219653 | 0.150 |
Why?
|
Food, Fortified | 1 | 2019 | 188 | 0.150 |
Why?
|
Sputum | 1 | 2020 | 502 | 0.150 |
Why?
|
Shock, Cardiogenic | 1 | 2023 | 731 | 0.150 |
Why?
|
Endoscopy, Digestive System | 1 | 2020 | 351 | 0.140 |
Why?
|
Treatment Outcome | 7 | 2023 | 64879 | 0.140 |
Why?
|
Retrospective Studies | 7 | 2024 | 80121 | 0.140 |
Why?
|
Aneurysm | 1 | 2020 | 337 | 0.140 |
Why?
|
Registries | 2 | 2023 | 8434 | 0.140 |
Why?
|
Constipation | 1 | 2021 | 561 | 0.140 |
Why?
|
Echocardiography, Transesophageal | 1 | 2023 | 1108 | 0.140 |
Why?
|
Phenotype | 2 | 2024 | 16532 | 0.130 |
Why?
|
Sweden | 1 | 2019 | 1381 | 0.130 |
Why?
|
Triglycerides | 1 | 2024 | 2475 | 0.130 |
Why?
|
Glomerular Filtration Rate | 1 | 2023 | 2168 | 0.120 |
Why?
|
Cholesterol | 1 | 2024 | 2923 | 0.120 |
Why?
|
Aged | 6 | 2024 | 168617 | 0.120 |
Why?
|
Adult | 8 | 2024 | 219390 | 0.120 |
Why?
|
Incidence | 2 | 2024 | 21336 | 0.120 |
Why?
|
Diarrhea | 1 | 2021 | 1340 | 0.120 |
Why?
|
Cholesterol, LDL | 1 | 2024 | 2417 | 0.120 |
Why?
|
Infant | 4 | 2021 | 35941 | 0.120 |
Why?
|
Food Hypersensitivity | 1 | 2021 | 692 | 0.110 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2018 | 664 | 0.110 |
Why?
|
Prognosis | 2 | 2024 | 29561 | 0.110 |
Why?
|
Coronary Vessels | 1 | 2024 | 3112 | 0.110 |
Why?
|
C-Reactive Protein | 1 | 2024 | 3823 | 0.100 |
Why?
|
Hearing Loss | 1 | 2018 | 780 | 0.090 |
Why?
|
Child, Preschool | 5 | 2021 | 41935 | 0.090 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2020 | 1400 | 0.090 |
Why?
|
Stomach Neoplasms | 1 | 2020 | 1422 | 0.080 |
Why?
|
Glucocorticoids | 1 | 2018 | 2142 | 0.080 |
Why?
|
Laparoscopy | 1 | 2020 | 2157 | 0.070 |
Why?
|
Genome-Wide Association Study | 2 | 2023 | 12580 | 0.070 |
Why?
|
Immunity, Innate | 1 | 2019 | 3046 | 0.070 |
Why?
|
Body Mass Index | 1 | 2024 | 12874 | 0.070 |
Why?
|
Cross-Sectional Studies | 2 | 2024 | 25860 | 0.060 |
Why?
|
Prospective Studies | 3 | 2024 | 54204 | 0.060 |
Why?
|
India | 2 | 2021 | 2343 | 0.060 |
Why?
|
Kidney | 1 | 2018 | 7066 | 0.050 |
Why?
|
Adolescent | 3 | 2020 | 87560 | 0.050 |
Why?
|
Cohort Studies | 1 | 2024 | 41247 | 0.050 |
Why?
|
Single-Blind Method | 1 | 2023 | 1574 | 0.040 |
Why?
|
Receptors, Calcitriol | 1 | 2022 | 359 | 0.040 |
Why?
|
Recurrence | 2 | 2022 | 8469 | 0.040 |
Why?
|
Manometry | 1 | 2021 | 454 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 20461 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2022 | 15728 | 0.030 |
Why?
|
Rectum | 1 | 2021 | 896 | 0.030 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2020 | 1547 | 0.030 |
Why?
|
Area Under Curve | 1 | 2020 | 1634 | 0.030 |
Why?
|
Abdominal Pain | 1 | 2021 | 1064 | 0.030 |
Why?
|
HIV Infections | 1 | 2020 | 17128 | 0.030 |
Why?
|
Respiration, Artificial | 1 | 2023 | 2616 | 0.030 |
Why?
|
Polymorphism, Genetic | 1 | 2022 | 4286 | 0.020 |
Why?
|
Echocardiography | 1 | 2023 | 4971 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2023 | 3193 | 0.020 |
Why?
|
Heart | 1 | 2023 | 4390 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2020 | 4546 | 0.020 |
Why?
|
Genotype | 1 | 2022 | 12940 | 0.020 |
Why?
|
Lung | 1 | 2020 | 9982 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39216 | 0.010 |
Why?
|
Brain | 1 | 2020 | 26863 | 0.010 |
Why?
|
Concepts
(137)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(16)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_